Currently, HCC diagnosis primarily relies on imaging techniques, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and serum biomarkers such as alpha-fetoprotein (AFP) [5]. This evidence concerns the gene AFP and hepatocellular carcinoma.